<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Cardiovasc Magn Reson</journal-id><journal-id journal-id-type="iso-abbrev">J Cardiovasc Magn Reson</journal-id><journal-title-group><journal-title>Journal of Cardiovascular Magnetic Resonance</journal-title></journal-title-group><issn pub-type="ppub">1097-6647</issn><issn pub-type="epub">1532-429X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3559772</article-id><article-id pub-id-type="publisher-id">1532-429X-15-S1-P185</article-id><article-id pub-id-type="doi">10.1186/1532-429X-15-S1-P185</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Diabetes remains an independent risk factor for adverse remodeling following acute myocardial infarction even with quantification of total infarct size and change in myocardial extracellular volume fraction by CMR</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Heydari</surname><given-names>Bobby</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Shah</surname><given-names>Ravi</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Abbasi</surname><given-names>Siddique</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Feng</surname><given-names>Jiazuo H</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Farhad</surname><given-names>Hoshang</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Neilan</surname><given-names>Tomas G</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A7"><name><surname>Blankstein</surname><given-names>Ron</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A8"><name><surname>van der Geest</surname><given-names>Rob J</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A9"><name><surname>Abdullah</surname><given-names>Shuaib</given-names></name><xref ref-type="aff" rid="I4">4</xref></contrib><contrib contrib-type="author" id="A10"><name><surname>Francis</surname><given-names>Sanjeev</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A11"><name><surname>Hoffmann</surname><given-names>Udo</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A12"><name><surname>Jerosch-Herold</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A13"><name><surname>Kwong</surname><given-names>Raymond Y</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>Brigham and Women's Hospital, Boston, MA, USA</aff><aff id="I2"><label>2</label>Department of Radiology, Leiden University Medical Center, Leiden, Netherlands</aff><aff id="I3"><label>3</label>Massachusetts General Hospital, Boston, MA, USA</aff><aff id="I4"><label>4</label>North Texas VA Medical Center, Dallas, TX, USA</aff><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>30</day><month>1</month><year>2013</year></pub-date><volume>15</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">Abstracts of the 16th Annual SCMR Scientific Sessions</named-content><named-content content-type="supplement-sponsor">Publication of this supplement is fully supported by the Society for Cardiovascular Magnetic Resonance.</named-content></supplement><fpage>P185</fpage><lpage>P185</lpage><permissions><copyright-statement>Copyright &#x000a9;2013 Heydari et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Heydari et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.jcmr-online.com/content/15/S1/P185"/><conference><conf-date>31 January-3 February 2013</conf-date><conf-name>16th Annual SCMR Scientific Sessions</conf-name><conf-loc>San Francisco, CA, USA</conf-loc></conference></article-meta></front><body><sec><title>Background</title><p>Diabetes (DM) has important implications on LV remodeling and prognosis following acute myocardial infarction (MI). We explored the impact of diabetic heart disease independent of traditional risk factors, infarct size, and myocardial extracellular volume fraction (MECVF).</p></sec><sec sec-type="methods"><title>Methods</title><p>We prospectively studied 105 patients with acute MI from the ongoing PROSPECT-CMR clinical trial. Subjects underwent CMR 2 to 4 weeks following MI with follow-up scan at 6-months. Presence of diabetes was determined by history and laboratory testing. Total infarct size was calculated according to previously described full width half-maximum method. MECVF was quantified by serial sampling of T1 ratios of myocardium remote from infarct and blood pool corrected for hematocrit. Sampling was performed in 5-minute intervals beginning 5 minutes and ending 30 minutes after contrast administration from 3 parallel short-axis slices of the heart. Adverse remodeling was defined as a positive change in left ventricular diastolic volume index of greater than 10% at follow-up.</p></sec><sec sec-type="results"><title>Results</title><p>Thirty-one patients (30%) had a history of type 2 diabetes mellitus (DM) preceding MI. Baseline characteristics and change in mean segmental MECVF are shown in Table <xref ref-type="table" rid="T1">1</xref>.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Baseline Characteristics and Change in MECVF stratified by Presence of DM (n=105)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center"/><th align="center">DM Present</th><th align="center">DM Absent</th><th align="center">P value</th></tr></thead><tbody><tr><td align="center">Age</td><td align="center">61.6&#x000b1;9.0</td><td align="center">56.8&#x000b1;11.9</td><td align="center">0.03</td></tr><tr><td align="center">Male</td><td align="center">94%</td><td align="center">74%</td><td align="center">0.03</td></tr><tr><td align="center">Hx Hypertension</td><td align="center">71%</td><td align="center">47%</td><td align="center">0.03</td></tr><tr><td align="center">Hx Hypercholesterolemia</td><td align="center">87%</td><td align="center">57%</td><td align="center">0.003</td></tr><tr><td align="center">Hx Coronary Artery Disease</td><td align="center">55%</td><td align="center">42%</td><td align="center">0.28</td></tr><tr><td align="center">BMI</td><td align="center">30.4&#x000b1;5.8</td><td align="center">28.9&#x000b1;5.4</td><td align="center">0.25</td></tr><tr><td align="center">LVEF (%)</td><td align="center">54.0&#x000b1;10.4</td><td align="center">55.0&#x000b1;8.2</td><td align="center">0.68</td></tr><tr><td align="center">LVEDV (ml)</td><td align="center">173.7&#x000b1;50.2</td><td align="center">173.0&#x000b1;40.0</td><td align="center">0.95</td></tr><tr><td align="center">Total Infarct Size (g)</td><td align="center">13.6&#x000b1;12.5</td><td align="center">15.1&#x000b1;11.3</td><td align="center">0.56</td></tr><tr><td align="center">Change in mean segmental MECVF</td><td align="center">-0.023&#x000b1;0.05</td><td align="center">-0.014&#x000b1;0.07</td><td align="center">0.53</td></tr></tbody></table></table-wrap><p>Unadjusted analysis of clinical and CMR characteristics, including change in mean segmental fibrotic index, revealed that only history of DM was associated with adverse remodeling (LR &#x003c7;2 = 4.6). In multivariable logistic regression analysis, only history of DM remained significantly associated with adverse remodeling at 6 months (LR &#x003c7;2 = 4.8) (Figure <xref ref-type="fig" rid="F1">1</xref>). Change in total infarct size, mean segmental MECVF, and other baseline clinical characteristics, including LVEF, did not reach statistical significance.</p><fig id="F1" position="float"><label>Figure 1</label><graphic xlink:href="1532-429X-15-S1-P185-1"/></fig></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Diabetics represent a particularly high risk cohort following acute MI. Our results revealed that presence of DM was an independent risk factor for adverse LV remodeling, including baseline clinical variables, LVEF, change in total infarct size and mean segmental MECVF. We postulate that there are independent mechanisms for adverse remodeling in diabetics, such as genetic predisposition and inflammation, that contribute to adverse remodeling following acute infarction.</p></sec><sec><title>Funding</title><p>National Heart Lung and Blood Institute, National Institutes of Health (RO1-HL091157).</p><p>Dr. Heydari's salary is supported by the Alberta Heritage Foundation for Medical Research.</p></sec></body></article>